2021 global life sciences outlook
Possibility is now reality, sustaining forward momentum
Navigating the pandemic has been an all-encompassing, once-in-a-lifetime challenge. Globally, life sciences companies responded with leadership and are emerging stronger. Explore how life sciences companies responded and areas where they can build resiliency going forward.
Understanding human behavior in designing a future of health
In the future of health—where data and technology continue to advance exponentially—will human behavior still prevent us from becoming a healthier society? How can we conquer the age-old problem of behavior change both with, and in spite of, technology?
Overcoming biopharma's trust deficit
Why people mistrust the biopharma industry--and what to do about it
Consumers may appreciate pharma companies’ efforts to speed up the process of bringing COVID-19 vaccines to market. How might biopharma continue to innovate while building trust?